KKG Immunmonitoring Publikationsliste

Size: px
Start display at page:

Download "KKG Immunmonitoring Publikationsliste"

Transcription

1 Bohne F, Chmielewski M, Ebert G, Wiegmann K, Kürschner T, Schulze A, Urban S, Krönke M, Abken H, Protzer U.: T cells redirected against Hepatitis-B-virus surface proteins eliminate infected hepatocytes. Gastroenterology 2008, 134: Bohne F, Protzer U.: Adoptive T-cell therapy as a therapeutic option in chronic viral hepatitis. J. Viral Hepatitis 2007, 14, Suppl 1: Brill, T.H., Kübler, H.R., Pohla, H., Buchner, A., Fend, F., Schuster, T., van Randenborgh, H., Paul, R., Kummer, T., Plank, C., Eisele, B., Breul, J., Hartung, R., Schendel, D.J., Gansbacher, B.: Therapeutic vaccination with an interleukin-2interferon-g-secreting allogeneic tumor vaccine in patients with progressive castration-resistant prostate cancer: a phase I/II trial Hum.Gene. Ther. 20, 1-11 (2009) Brill, T.H.*, Kübler, H.R.*, von Randenborgh, H.*, Fend, F.*, Pohla, H.*, Breul, J.*, Hartung, R.*, Paul, R.*, Schendel, D.J., Gansbacher, B.*: Allogeneic retrovirally transduced, IL-2- and IFN-gamma-secreting cancer cell vaccine in patients with hormone refractory prostate cancer--a phase I clinical trial. J. Gene Med. 9 (7), (2007) Butterfield, L.H., Disis, M.L., Fox, B.A., Lee, P.P., Khleif, S.N, Thurin, M., Trinchieri, G., Wang, E., Wigginton, J., Chaussabel, D., Coukos, G., Dhodapkar, M., Hakansson, L., Janetzki, S., Kleen, T.O., Kirkwood, J.M., Maccalli, C., Maecker, H., Maio, M., Malyguine, A., Masucci, G., Palucka, A.K., Potter, D.M., Ribas, A., Rivoltini, L., Schendel, D., Seliger, B., Selvan, S., S.L.ingluff, C.L., Stroncek, D.F., Streicher, H., Wu, X.F., Zeskind, B., Zhao, Y.D., Zocca, M.B., Zwierzina, H., Marincola, F.M.: A systematic approach to biomarker discovery; Preamble to "the isbtc-fda taskforce on immunotherapy biomarkers" J. Transl. Med. 6, 81 (2008) Cornberg M, Protzer U, Dollinger M, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Schirmacher P, Fleig WE, Manns M. Prophylaxis, diagnosis and therapy of Hepatitis-B-Virus-(HBV-)Infection: Upgrade of the german guideline. Z. Gastroenterologie 2007, 45: Cosma, A., Nagaraj, R., Staib, C., Diemer, C.*, Wopfner, F.*, Schätzl, H.*, Busch, D.H., Sutter, G., Goebel, F.D.*, Erfle, V.: Evaluation of modified Vaccinia Virus Ankara as an alternative vaccine against smallpox in chronically HIV Type 1-Infected individuals undergoing HAART. Aids Res. Hum.Retrov. 23, (2007) Ebelt, K., Babaryka, G., Frankenberger, B., Stief, C.G., Eisenmenger, W., Kirchner, T., Schendel, D.J., Noessner, E.: Prostate cancer lesions are surrounded by FOXP3(+), PD-1(+) and B7-H1(+)lymphocyte clusters Eur. J. Cancer 45 (9), (2009) Ebelt K, Babaryka G, Figel AM, Pohla H, Buchner A, Stief CG, Eisenmenger W, Kirchner T, Schendel DJ, Noessner E.: Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma. Prostate Jan 1;68(1):1-10

2 Endl, J.*, Rosinger, S.*, Schwarz, B.*, Friedrich, S.-O.*, Rothe, G.*, Karges, W.*, Schlosser, M.*, Eiermann, T.*, Schendel, D.J., Boehm, B.O.*: Co-expression of CD25 and Ox40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes. Diabetes 55, (2006) Frankenberger, B., Noessner, E., Schendel, D.J.: Immune suppression in renal cell carcinoma. Semin. Cancer Biol. 17 (4), (2007) Frankenberger, B., Regn, S., Geiger, C., Noessner, E., Falk, C.S., Pohla, H.*, Javorovic, M., Silberzahn, T., Wilde, S., Buchner, A.*, Siebels, M.*, Oberneder, R.*, Willimsky, G.*, Pezzutto, A.*, Blankenstein, T.*, Schendel, D.J.: Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells. World J. Urol. 23; (2005) Frankenberger, B., Pohla, H. *, Noessner, E., Willimsky, G.*, Papier, B., Pezzutto, A.*, Kopp, J.*, Oberneder, R.*, Blankenstein, T.*, Schendel, D.J.: Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs. ( equally contributed) Clin. Cancer Res. 11; (2005) Geiger, C., Nossner, E., Frankenberger, B., Falk, C.S., Pohla, H., Schendel, D.J.: Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma J. Mol. Med. 87 (6), (2009) Gudbjartsson, D.F., Bjornsdottir, U.S., Halapi, E., Helgadottir, A., Sulem, P., Jonsdottir, G.M., Thorleifsson, G., Helgadottir, H., Steinthorsdottir, V., Stefansson, H., Williams, C., Hui, J., Beilby, J., Warrington, N.M., James, A., Palmer, L.J., Koppelman, G.H., Heinzmann, A., Krueger, M., Boezen, H.M., Wheatley, A., Altmuller, J., Shin, H.D., Uh, S.T., Cheong, H.S., Jonsdottir, B., Gislason, D., Park, C.S., Rasmussen, L.M., Porsbjerg, C., Hansen, J.W., Backer, V., Werge, T., Janson, C., Jonsson, U.B., Ng, M.C.Y., Chan, J., So, W.Y., Ma, R., Shah, S.H., Granger, C.B., Quyyumi, A.A., Levey, A.I., Vaccarino, V., Reilly, M.P., Rader, D.J., Williams, M.J.A., van Rij, A.M., Jones, G.T., Trabetti, E., Malerba, G., Pignatti, P.F., Boner, A., Pescollderungg, L., Girelli, D., Olivieri, O., Martinelli, N., Ludviksson, B.R., Ludviksdottir, D., Eyjolfsson, G.I., Arnar, D., Thorgeirsson, G., Deichmann, K., Thompson, P.J., Wjst, M., Hall, I.P., Postma, D.S., Gislason, T., Gulcher, J., Kong, A., Jonsdottir, I., Thorsteinsdottir, U., Stefansson, K.: Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction Nat. Genet. 41 (3), (2009) Hartl, D.*, Griese, M.*, Nicolai, T.*, Zissel, G.*, Prell, C.*, Reinhardt, D.*, Schendel, D.J., Krauss- Etschmann, S.: A role for MCP-I/CCR2 in interstitial lung disease in children. Resp. Res., (2005) Hartl, D.*, Griese, M.*, Nicolai, T.*, Zissel, G.*, Prell, C.*, Konstantopoulos, N.*, Gruber, R.*, Reinhardt, D.*, Schendel, D.J., Krauss-Etschmann, S.*: Pulmonary chemokines and their receptors differentiate children with asthma and chronic cough. J. Allergy Clin. Immunol. 115, (2005)

3 Hartl, D.*, Griese, M.*, Kappler, M.*, Zissel, G.*, Reinhardt, D.*, Rebhan, C.*, Schendel, D.J., Krauss- Etschmann, S.: Pulmonary Th2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J. Allergy Clin. Immunol. 117, (2006) Hartl, D.*, Koller, B., Mehlhorn, A.T.*, Reinhardt, D.*, Nicolai, T.*, Schendel, D.J., Griese, M.*, Krauss-Etschmann, S.: Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J. Allergy Clin. Immunol. 119 (5), (2007) Hoffmann, D., Seebach, J., Cosma, A., Goebel, F.D., Strimmer, K., Schätzl, H.M., Erfle, V.: Therapeutic vaccination reduces HIV protein sequence variability. FASEB Journal: 22(2), (2008) Javorovic M, Wilde S, Zobywalski A, Noessner E, Lennerz V, Wölfel T, Schendel DJ.: Inhibitory effect of RNA pool complexity on stimulatory capacity of RNA-pulsed dendritic cells J. Immunother. (1997) Jan;31(1): Javorovic, M., Pohla, H.*, Frankenberger, B., Wölfel, T.*, Schendel, D.J.: RNA transfer by electroporation into mature dendritic cells leading to reactivation of effector-memory cytotoxic T lymphocytes: a quantitative analysis. Mol Ther. 12; (2005) Kastenmüller, W., Gasteiger, G., Stross, L., Busch, D.H., Drexler, I.: Mucosal Application of a Lyophilized Viral Vector Vaccine Confers Systemic and Protective Immunity toward Intracellular Pathogens J. Immunol. 182 (5), (2009) Kastenmüller, W., Gasteiger, G., Gronau, J.H., Baier, R., Ljapoci, R., Busch, D.H., Drexler, I.: Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination. J. Exp. Med. 204 (9), (2007) Krauss-Etschmann, S., Niedermaier, S., Beyer, J., Campoy, C., Escolano, V., Decsi, T., Jakobik, V., Schendel, D.J., Demmelmair, H., Heinrich, J., Koletzko, B.V.: Current use of room disinfectants and allergic symptoms at the age of 4 years J. Allergy Clin. Immunol. 123 (5), (2009) Krauss-Etschmann, S. Hartl, D., Rzehak, P., Heinrich, J., Shadid, R., Del Carmen Ramírez-Tortosa, M., Campoy, C, Pardillo, S., Schendel, D.J., Decsi, T., Demmelmair, H., Koletzko, B.V., Nutraceuticals for Healthier Life Study Group: Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women. J. Allergy Clin. Immun. 121 (2), (2008) Krauss-Etschmann S, Shadid R, Campoy C, Hoster E, Demmelmair H, Jiménez M, Gil A, Rivero M, Veszprémi B, Decsi T, Koletzko BV.: Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am. J. Clin. Nutr. 85 (5), (2007)

4 Krauss-Etschmann, S., Hartl, D., Heinrich, J., Thaqi, A., Prell, C., Campoy, C.*, Molina, F.S.*, Hector, A.*, Decsi,T.*, Schendel, D.J., Koletzko, B.V.*: Association between levels of Toll-like receptors 2 and 4 and CD14 mrna and allergy in pregnant women and their offspring. Clin. Immunol. 118, (2006) Krönig, H., Hofer, K., Conrad, H., Guilaume, P., Muller, J., Schiemann, M., Lennerz, V., Cosma, A., Peschel, C., Busch, DH., Romero, P., Bernhard, H.: Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY- ESO-1 have potent anti-tumor activity Int. J. Cancer 125 (3), (2009) Kutscher, S., Dembek, C.J., Allgayer, S., Heltai, S., Stadlbauer, B., Biswas, P., Nozza, S., Tambussi, G., Bogner, J.R., Stellbrink, H.J., Goebel, F.D., Lusso, P., Tinelli, M., Poli, G., Erfle, V., Pohla, H., Malnati, M., Cosma, A.: The intracellular detection of MIP-1beta enhances the capacity to detect IFN- gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT AIDS. Res. Ther. 5, 22 (2008) Levin, A., Hayouka, Z., Helfer, M., Brack-Werner, R., Friedler, A., Loyter, A.: Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration PLoS ONE 4 (1), e4155 (2009) Mamani-Matsuda, M., Cosma, A., Weller, S., Faili, A., Staib, C., Garçon, L., Hermine, O., Adoue, D., Fieschi, C., Pers, J.O., Arakelyan, N., Varet, B., Sauvanet, A., Berger, A., Paye, F., Andrieu, J.M., Michel, M., Godeau, B., Buffet, P., Reynaud, C.A., Weill, J.C.: The human spleen is the main reservoir for life long memory B-cells. Blood: Mar 3; [Epub ahead of print] (2008) Markoullis, K., Bulian, D.; Hölzlwimmer, G.; Quintanilla-Martinez, L.; Heiliger, K.J.; Zitzelsberger, H.; Scherb, H.; Mysliwietz, J.; Uphoff, C.C.; Drexler, H.G.; Adler, T.; Busch, D.H.; Schmidt, J.; Mahabir, E.: Mycoplasma contamination of murine embryonic stem cells affects cell parameters, germline transmission and chimeric progeny Transgenic Res 18 (1), (2009) Raffegerst, S.H.; Hoelzlwimmer, G.; Kunder, S.; Mysliwietz, J.; Quintanilla-Martinez, L.; Schendel, D.J.: Diverse hematological malignancies including hodgkin-like lymphomas develop in chimeric MHC class II transgenic mice PLoS ONE 4 (12), e8539 (2009) Renström, J., Istvanffy, R., Gauthier, K., Shimono, A., Mages, J., Jardon-Alvarez, A., Kröger, M., Schiemann, M., Busch, D.H., Esposito, I., Lang, R., Peschel, C., Oostendorp, R.A.: Secreted frizzled-related protein 1 extrinsically regulates cycling activity and maintenance of hematopoietic stem cells Cell Stem Cell 5 (2), (2009) Rothenaigner, I., Kramer, S., Meggendorfer, M., Rethwilm, A.*, Brack-Werner, R.: Transduction of human neural progenitor cells with foamy virus vectors for differentiationdependent gene expression. Gene Ther. Doi: /gt (2008)

5 Rüttinger D, van den Engel NK, Winter H, Schlemmer M, Pohla H, Grützner S, Wagner B, Schendel DJ, Fox BA, Jauch KW, Hatz RA.: Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC : first clinical experience and evidence of an immune response. J. Transl. Med. 5:43, 1-14 (2007) Rüttinger, D.*, Winter, H.*, van den Engel, N.K.*, Hatz, R.A.*, Schlemmer, M.*, Pohla, H.*, Grützner, S.*, Schendel, D.J., Fox, B.A.*, Jauch, K.-W.*: Immunotherapy of lung cancer: an update. Onkologie 29; (2006) Scheich, F.*, Duyster, J.*, Peschel, C.*, Bernhard, H.: The immunogenicity of Bcr-Abl expressing dendritic cells is dependent on the Bcr-Abl kinase activity and dominated by Bcr-Abl regulated antigens. Blood 110 (7), (2007) Schendel, D.J.: Dendritic cell vaccine strategies for renal cell carcinoma. Opin. Biol.Ther. 7 (2), (2007) Schleypen, J.S., Baur, N., Kammerer, R.*, Nelson, P.J.*, Rohrmann, K.*, Gröne, E.F.*, Hohenfellner, M.*, Haferkamp, A.*, Pohla, H.*, Schendel, D.J., Falk, C.S., Noessner, E.: Cytotoxic markers and frequencies predict functional capacity of natural killer cells infiltrating renal cell carcinoma. Clin. Cancer Res. 12; (2006) Schlosser, E.*, Mueller, M.*, Fischer, S.*, Basta, S.*, Busch, D.H., Gander, B.*, Groettrup, M.*: TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine 26 (13), (2008) Schuster IG, Busch DH, Eppinger E, Kremmer E, Milosevic S, Hennard C, Kuttler C, Ellwart JW, Frankenberger B, Nössner E, Salat C, Bogner C, Borkhardt A, Kolb HJ, Krackhardt AM.: Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies. Blood 110, (2007) Shadid, R., Haarman, M.*, Knol, J.*, Theis, W.*, Beermann, C.*, Rjosk-Dendorfer, D.*, Schendel, D.J., Koletzko, B.V.*, Krauss-Etschmann, S.: Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity-a randomized, doubleblind, placebo-controlled study. Am. J. Clin. Nutr. 86 (5), (2007) Stemberger, C., Neuenhahn, M., Gebhardt, F.E., Schiemann, M., Buchholz, V.R., Busch, D.H.: Stem cell-like plasticity of naive and distinct memory CD8(+) T cell subsets Semin. Immunol. 21 (2), (2009) Stemberger, C.*, Huster, K.M., Koffler, M.*, Anderl, F.*, Schiemann, M.*, Wagner, H., Busch, D.H.: A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets.: Immunity 27 (6), (2007) Stemberger, C.*, Neuenhahn, M.*, Buchholz, V.R.*, Busch, D.H.: Origin of CD8+ Effector and Memory T Cell Subsets. Cell. Mol. Immunol. 4 (6), (2007)

6 Wilde, S.; Sommermeyer, D.; Frankenberger, B.; Schiemann, M.; Milosevic, S.; Spranger, S.; Pohla, H.; Uckert, W.; Busch, D.H.; Schendel, D.J.: Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity Blood 114 (10), (2009) Zobywalski, A., Javorovic, M., Frankenberger, B., Pohla, H.*, Kremmer, E., Bigalke, I., Schendel, D.J.: Generation of clinical grade dendritic cells with capacity to produce biologically active IL- 12p70. Biomed Central / J. Transl. Medicine 5:18, 1-16 (2007)

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor The immune system Basophil Neutrophil Bone marrow Eosinophil Myeloid progenitor Dendritic cell Pluripotent Stem cell Lymphoid progenitor Platelets Bone marrow Thymus NK cell T-cell B-cell Spleen Cancer

More information

Oncos Therapeutics: ONCOS THERAPEUTICS Personalized Cancer Immunotherapy. March 2015. Antti Vuolanto, COO and co-founder

Oncos Therapeutics: ONCOS THERAPEUTICS Personalized Cancer Immunotherapy. March 2015. Antti Vuolanto, COO and co-founder Oncos Therapeutics: Personalized Cancer Immunotherapy ONCOS THERAPEUTICS Personalized Cancer Immunotherapy March 2015 Antti Vuolanto, COO and co-founder 1 History of Oncos Therapeutics 2002 2007 2009 Research

More information

Chapter 17A: Adaptive Immunity Part I

Chapter 17A: Adaptive Immunity Part I Chapter 17A: Adaptive Immunity Part I 1. Overview of Adaptive Immunity 2. T and B Cell Production 3. Antigens & Antigen Presentation 4. Helper T cells 1. Overview of Adaptive Immunity The Nature of Adaptive

More information

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins Adaptive Immunity Chapter 17: Adaptive (specific) Immunity Bio 139 Dr. Amy Rogers Host defenses that are specific to a particular infectious agent Can be innate or genetic for humans as a group: most microbes

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: adoptive_immunotherapy 11/1993 3/2016 3/2017 3/2016 Description of Procedure or Service The spontaneous regression

More information

Dendritic Cells: A Basic Review *last updated May 2003

Dendritic Cells: A Basic Review *last updated May 2003 *last updated May 2003 Prepared by: Eric Wieder, PhD MD Anderson Cancer Center Houston, TX USA What is a dendritic cell? Dendritic cells are antigen-presenting cells (APCs) which play a critical role in

More information

Chapter 22: The Lymphatic System and Immunity

Chapter 22: The Lymphatic System and Immunity Chapter 22: The Lymphatic System and Immunity Introduction Immune system the body s defenses against pathogens that produce disease 2 types of immunity Nonspecific immune mechanisms (Innate immunity) Provide

More information

and Antigen Presentation

and Antigen Presentation 1 Innate Immunity and Antigen Presentation Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School 2 Lecture outline Innate immunity Receptors and mechanisms Roles in disease Antigen

More information

Predictive Biomarkers for Tumor Immunotherapy: Are we ready for clinical implementation? Howard L. Kaufman Rush University

Predictive Biomarkers for Tumor Immunotherapy: Are we ready for clinical implementation? Howard L. Kaufman Rush University Predictive Biomarkers for Tumor Immunotherapy: Are we ready for clinical implementation? Howard L. Kaufman Rush University Changing Paradigms in Cancer Treatment Potential Uses of Biomarkers Adverse event

More information

T Cell Maturation,Activation and Differentiation

T Cell Maturation,Activation and Differentiation T Cell Maturation,Activation and Differentiation Positive Selection- In thymus, permits survival of only those T cells whose TCRs recognize self- MHC molecules (self-mhc restriction) Negative Selection-

More information

NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY. Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds

NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY. Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds CANCER IMMUNOTHERAPY - Breakthrough of the Year in Science magazine 2013.

More information

The Multiple Myeloma Research Foundation Webinar Series Improving the Overall Understanding of Immunotherapy in Multiple Myeloma

The Multiple Myeloma Research Foundation Webinar Series Improving the Overall Understanding of Immunotherapy in Multiple Myeloma Improving the Overall Understanding of Immunotherapy in Multiple Myeloma Webinar 3, September 17, 2015 Engineering the Immune System to Recognize Myeloma Cells Speakers Moderator: David Avigan, MD Harvard

More information

Asthma (With a little SCID to start) Disclosures Outline Starting with the Immune System The Innate Immune System The Adaptive Immune System

Asthma (With a little SCID to start) Disclosures Outline Starting with the Immune System The Innate Immune System The Adaptive Immune System 1 2 3 4 5 6 7 8 9 Asthma (With a little SCID to start) Lauren Smith, MD CHKD Pediatric Allergy/Immunology Disclosures None Will be discussing some medications that are not yet FDA approved Outline SCID

More information

CHAPTER 14 CELL SURFACE MARKERS OF T-CELLS, B-CELLS AND MACROPHAGES

CHAPTER 14 CELL SURFACE MARKERS OF T-CELLS, B-CELLS AND MACROPHAGES CHAPTER 14 CELL SURFACE MARKERS OF T-CELLS, B-CELLS AND MACROPHAGES An understanding of the distinct families of molecules present on different cells of the immune system provides the tools for distinguishing

More information

The Adaptive Immune System

The Adaptive Immune System Chapter 17 Functional Anatomy of Prokaryotic and Eukaryotic Cells Lectures prepared by Christine L. Case The Adaptive Immune System Learning Objectives 17-1 Differentiate innate from adaptive immunity.

More information

Activation and effector functions of HMI

Activation and effector functions of HMI Activation and effector functions of HMI Hathairat Thananchai, DPhil Department of Microbiology Faculty of Medicine Chiang Mai University 25 August 2015 ว ตถ ประสงค หล งจากช วโมงบรรยายน แล วน กศ กษาสามารถ

More information

Immune Checkpoint Blockade in Acute Myeloid Leukemia. Kinsey McCormick Hematology Fellow s Conference January 10, 2014

Immune Checkpoint Blockade in Acute Myeloid Leukemia. Kinsey McCormick Hematology Fellow s Conference January 10, 2014 Immune Checkpoint Blockade in Acute Myeloid Leukemia Kinsey McCormick Hematology Fellow s Conference January 10, 2014 Overview Overview of immune checkpoints Immune checkpoints as mechanism of immune evasion

More information

Presenter Disclosure: Renier J. Brentjens, MD, PhD. Nothing to disclose

Presenter Disclosure: Renier J. Brentjens, MD, PhD. Nothing to disclose Presenter Disclosure: Renier J. Brentjens, MD, PhD Nothing to disclose Adoptive Therapy of Cancer with T cells Genetically Targeted to Tumor Associated Antigens through the Introduction of Chimeric Antigen

More information

Chimeric Antigen Receptor T Cell Therapy

Chimeric Antigen Receptor T Cell Therapy Chimeric Antigen Receptor T Cell Therapy Yi Lin, MD, PhD Mayo Clinic, Rochester, MN Alliance Spring Group Meeting - May 13, 2016 Presentation Objectives l Scientific overview of chimeric antigen receptor

More information

BVIG/SBMI Meeting 2007. Bart N. Lambrecht, MD, PhD. Department of Respiratory Diseases University Hospital Gent, Belgium

BVIG/SBMI Meeting 2007. Bart N. Lambrecht, MD, PhD. Department of Respiratory Diseases University Hospital Gent, Belgium Dendritic cells : from bench to bedside BVIG/SBMI Meeting 2007 Bart N. Lambrecht, MD, PhD Department of Respiratory Diseases University Hospital Gent, Belgium Outline Role of DCs in the immune system Role

More information

Pathogens and the immune system

Pathogens and the immune system Review of lecture 7 Pathogens and the immune system Veronica Leautaud, Ph.D. vl2@ rice.edu BRC 511 / 530-lab Lecture 8 BIOE 301-Bioengineering and World Health Science Science is the human activity of

More information

Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1

Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1 9/8/2015 Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1 Stefan Eichmüller, PhD GMP & T Cell Therapy Unit, German Cancer Research Center, Heidelberg, Germany

More information

Chapter 43: The Immune System

Chapter 43: The Immune System Name Period Our students consider this chapter to be a particularly challenging and important one. Expect to work your way slowly through the first three concepts. Take particular care with Concepts 43.2

More information

Immunology and immunotherapy in allergic disease

Immunology and immunotherapy in allergic disease Immunology and immunotherapy in allergic disease Jing Shen, MD Faculty Advisor: Matthew Ryan, MD The University of Texas Medical Branch Department of Otolaryngology Grand Rounds Presentation February 2005

More information

Immunotherapy Concept Turned Reality

Immunotherapy Concept Turned Reality Authored by: Jennifer Dolan Fox, PhD VirtualScopics Inc. jennifer_fox@virtualscopics.com +1 585 249 6231 Immunotherapy Concept Turned Reality Introduction While using the body s own immune system as a

More information

Acute Leukemia - D Savage - 8 January chronic leukemia lymphoma myeloma. differentiated

Acute Leukemia - D Savage - 8 January chronic leukemia lymphoma myeloma. differentiated Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Total WBC > 60 leukemoid reaction acute leukemia Blast Pro Myel Meta Band Seg Lymph 0 0 0 2 13 82 3 82

More information

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015 The role of IBV proteins in protection: cellular immune responses COST meeting WG2 + WG3 Budapest, Hungary, 2015 1 Presentation include: Laboratory results Literature summary Role of T cells in response

More information

CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy

CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy Joseph M. Tuscano, Jason Kato, David Pearson, Chengyi Xiong, Laura Newell, Yunpeng Ma, David R. Gandara,

More information

Name (print) Name (signature) Period. (Total 30 points)

Name (print) Name (signature) Period. (Total 30 points) AP Biology Worksheet Chapter 43 The Immune System Lambdin April 4, 2011 Due Date: Thurs. April 7, 2011 You may use the following: Text Notes Power point Internet One other person in class "On my honor,

More information

IMMUNOLOGY STRUCTURE AND FUNCTION OF IMMUNE SYSTEM

IMMUNOLOGY STRUCTURE AND FUNCTION OF IMMUNE SYSTEM 59 IMMUNOLOGY STRUCTURE AND FUNCTION OF IMMUNE SYSTEM 59.1 INTRODUCTION The immune system is engaged in a constant surveillance of the body for pathogens or tumors. Whether disease develops depends on

More information

Identification of Tick-Borne Encephalitis Virus CD4+ and CD8+ T-Cell Epitopes in Vaccinated or Naturally Infected Humans

Identification of Tick-Borne Encephalitis Virus CD4+ and CD8+ T-Cell Epitopes in Vaccinated or Naturally Infected Humans Identification of Tick-Borne Encephalitis Virus CD4+ and CD8+ T-Cell Epitopes in Vaccinated or Naturally Infected Humans Schwaiger Julia Clinical Institute of Virology 29.06.2009 1 Thank you! Franz X.

More information

Microbiology AN INTRODUCTION EIGHTH EDITION

Microbiology AN INTRODUCTION EIGHTH EDITION TORTORA FUNKE CASE Microbiology AN INTRODUCTION EIGHTH EDITION Differentiate between innate and acquired immunity. Chapter 17 Specific Defenses of the Host: The Immune Response B.E Pruitt & Jane J. Stein

More information

Antigens have specific regions where antibodies bind to them Antigens are usually molecules on the surface of viruses or foreign cells Antigenic

Antigens have specific regions where antibodies bind to them Antigens are usually molecules on the surface of viruses or foreign cells Antigenic Bio 100 Guide 22 Antigens have specific regions where antibodies bind to them Antigens are usually molecules on the surface of viruses or foreign cells Antigenic determinants are the specific regions on

More information

Biological Therapies for Cancer

Biological Therapies for Cancer Biological Therapies for Cancer Key Points Biological therapies use the body's immune system to fight cancer or to lessen the side effects that may be caused by some cancer treatments. Biological therapies

More information

The Four Pillars of Cancer Therapy

The Four Pillars of Cancer Therapy Improving the Overall Understanding of Immunotherapy in Multiple Myeloma Webinar 2, August 19, 2015 Myeloma Vaccines: A New Use of a Time-Tested Treatment The Four Pillars of Cancer Therapy Surgery Radiation

More information

Immune Therapy for Pancreatic Cancer

Immune Therapy for Pancreatic Cancer Immune Therapy for Pancreatic Cancer December 16, 2014 If you experience technical difficulty during the presentation: Contact WebEx Technical Support directly at: US Toll Free: 1-866-229-3239 Toll Only:

More information

New developments in antigen-specific immunotherapies Novel therapeutic vaccines offer hope in the fight against chronic infectious disease and cancer

New developments in antigen-specific immunotherapies Novel therapeutic vaccines offer hope in the fight against chronic infectious disease and cancer New developments in antigen-specific immunotherapies Novel therapeutic vaccines offer hope in the fight against chronic infectious disease and cancer Vaccination has been used effectively for more than

More information

Overview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development

Overview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development Overview B cell development Transcriptional cascades Amazing aspects of lineage plasticity Conventional (B2) B cell development What happens to an autoreactive B cell? B1 vs B2 cells Key anatomical sites

More information

Modelling and analysis of T-cell epitope screening data.

Modelling and analysis of T-cell epitope screening data. Modelling and analysis of T-cell epitope screening data. Tim Beißbarth 2, Jason A. Tye-Din 1, Gordon K. Smyth 1, Robert P. Anderson 1 and Terence P. Speed 1 1 WEHI, 1G Royal Parade, Parkville, VIC 3050,

More information

2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders

2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders UPDATE ECIL-4 2011 2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders Jan Styczynski, Hermann Einsele, Rafael de la Camara, Catherine Cordonnier,

More information

The Adaptive Immune Response. B-cells

The Adaptive Immune Response. B-cells The Adaptive Immune Response B-cells FUNCTIONS OF THE IMMUNE SYSTEM: Recognize, destroy and clear a diversity of pathogens. Initiate tissue and wound healing processes. Recognize and clear damaged self

More information

Biological Therapies for Cancer: Questions and Answers. Key Points

Biological Therapies for Cancer: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Biological Therapies for

More information

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist MULTIPLE MYELOMA Dr Malkit S Riyat MBChB, FRCPath(UK) Consultant Haematologist Multiple myeloma is an incurable malignancy that arises from postgerminal centre, somatically hypermutated B cells.

More information

Chapter 43: The Immune System

Chapter 43: The Immune System Name Period Our students consider this chapter to be a particularly challenging and important one. Expect to work your way slowly through the first three concepts. Take particular care with Concepts 43.2

More information

Immuno-Oncology Therapies to Treat Lung Cancer

Immuno-Oncology Therapies to Treat Lung Cancer Immuno-Oncology Therapies to Treat Lung Cancer What you need to know ONCHQ14NP07519 Introduction: Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body s own

More information

A Genetic Analysis of Rheumatoid Arthritis

A Genetic Analysis of Rheumatoid Arthritis A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.

More information

What are cytokines and chemokines? What do cytokines, chemokines and growth factors do? Lecture 11

What are cytokines and chemokines? What do cytokines, chemokines and growth factors do? Lecture 11 Lecture 11 T-cell Effector Mechanisms-II: Cytokine Secretion & T-cell Polarization September 21, 2005 Chris Schindler cws4@columbia.edu What do cytokines, chemokines and growth factors do? They direct

More information

Prospects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS

Prospects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS Prospects for Vaccines against Hepatitis C Viruses T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS HCV Vaccine Prevention strategies Protective immunity Barriers and solutions Vaccine candidates

More information

Micro 204 Tumor Immunology.

Micro 204 Tumor Immunology. Micro 204 Tumor Immunology Lewis.Lanier@ucsf.edu Immunological Surveillance Ehrlich, Burnet & Thomas Paul Ehrlich (1909) Concept of cancer immunosurveillance. Predicted that cancer would occur at incredible

More information

Cytoreductive Therapy for Autologous Cell Therapy in HIV

Cytoreductive Therapy for Autologous Cell Therapy in HIV Cytoreductive Therapy for Autologous Cell Therapy in HIV Ronald Mitsuyasu, MD Professor of Medicine UCLA Center for Clinical AIDS Research and Education (CARE Center) HSC Transfer from CCR5-delta 32 Donor

More information

The Immune System: A Tutorial

The Immune System: A Tutorial The Immune System: A Tutorial Modeling and Simulation of Biological Systems 21-366B Shlomo Ta asan Images taken from http://rex.nci.nih.gov/behindthenews/uis/uisframe.htm http://copewithcytokines.de/ The

More information

B Cells and Antibodies

B Cells and Antibodies B Cells and Antibodies Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School Lecture outline Functions of antibodies B cell activation; the role of helper T cells in antibody production

More information

Bioinformatics for cancer immunology and immunotherapy

Bioinformatics for cancer immunology and immunotherapy Bioinformatics for cancer immunology and immunotherapy Zlatko Trajanoski Biocenter, Division for Bioinformatics Innsbruck Medical University Innrain 80, 6020 Innsbruck, Austria Email: zlatko.trajanoski@i-med.ac.at

More information

T Cell Immunotherapy for Cancer

T Cell Immunotherapy for Cancer T Cell Immunotherapy for Cancer Chimeric Antigen Receptors Targeting Tag-72 Glycoprotein for Colorectal Cancer Mitchell H. Finer Ph.D Genetix Pharmaceuticals Inc Work Completed at Cell Genesys Inc T Cell

More information

11/20/2011. Outline. Immune System Function. Terminology. Two Types of Immune Defense. Innate Immunity = Non Specific

11/20/2011. Outline. Immune System Function. Terminology. Two Types of Immune Defense. Innate Immunity = Non Specific Chapter 43 Immune System Outline I. Nonspecific Defenses A. Barrier B. Protective proteins C. Phagocytes D. Natural killer cells E. Inflammatory reaction II. Specific Defenses A. B cells Antibody mediated

More information

This presentation may contain forward-looking statements, which reflect Trillium's current expectation regarding future events. These forward-looking

This presentation may contain forward-looking statements, which reflect Trillium's current expectation regarding future events. These forward-looking Q1/2016 This presentation may contain forward-looking statements, which reflect Trillium's current expectation regarding future events. These forward-looking statements involve risks and uncertainties

More information

2) Macrophages function to engulf and present antigen to other immune cells.

2) Macrophages function to engulf and present antigen to other immune cells. Immunology The immune system has specificity and memory. It specifically recognizes different antigens and has memory for these same antigens the next time they are encountered. The Cellular Components

More information

Module 3: Development of immune cells

Module 3: Development of immune cells Module 3: Development of immune cells Lecture 15: Development of Lymphocytes (Part I) Pluripotent stem cells and fetal liver are considered as hematopoietic stem cells in the body which give rise to lineages

More information

IMMUNOLOGY. An Overview of Immunity: Innate And Adaptive Immunity

IMMUNOLOGY. An Overview of Immunity: Innate And Adaptive Immunity IMMUNOLOGY An Overview of Immunity: Innate And Adaptive Immunity Tapasya Srivastava and Subrata Sinha Department of Biochemistry All India Institute of Medical Sciences New Delhi 110 029 CONTENTS Concept

More information

Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center

Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center Bodnar s Law Simple Things are Important Very Simple Things are Very Important

More information

ΔΕΝΤΡΙΤΙΚΑ ΚΥΤΤΑΡΑ ΚΑΙ ΕΜΒΟΛΙΑ ΓΙΑ ΤΟΝ ΚΑΡΚΙΝΟ DENDRITIC CELLS AND CANCER VACCINES

ΔΕΝΤΡΙΤΙΚΑ ΚΥΤΤΑΡΑ ΚΑΙ ΕΜΒΟΛΙΑ ΓΙΑ ΤΟΝ ΚΑΡΚΙΝΟ DENDRITIC CELLS AND CANCER VACCINES ΔΕΝΤΡΙΤΙΚΑ ΚΥΤΤΑΡΑ ΚΑΙ ΕΜΒΟΛΙΑ ΓΙΑ ΤΟΝ ΚΑΡΚΙΝΟ DENDRITIC CELLS AND CANCER VACCINES David Hunt. Cell Systems Initiative, U. of Washington. Βαίος Καρανίκας EU Marie Curie Fellow Μοναδα Ανοσολογίας Καρκίνου

More information

AN INTRODUCTION TO IMMUNOLOGY. Paul Thomas Unit 1 Department of Immunology St. Jude Children s Research Hospital

AN INTRODUCTION TO IMMUNOLOGY. Paul Thomas Unit 1 Department of Immunology St. Jude Children s Research Hospital AN INTRODUCTION TO IMMUNOLOGY Paul Thomas Unit 1 Department of Immunology St. Jude Children s Research Hospital CATEGORIES OF PATHOGENS Viruses (~0.2 microns) Bacteria (1-2 microns) Parasites (Millimeters)

More information

Alireza Ostadrahimi 1, Jamal Eivazi Ziaei 2, Ali Esfahani 2, Mohammad Asghari Jafarabadi 3, Aliakbar Movassaghpourakbari 2, Nazila Farrin 4 * Abstract

Alireza Ostadrahimi 1, Jamal Eivazi Ziaei 2, Ali Esfahani 2, Mohammad Asghari Jafarabadi 3, Aliakbar Movassaghpourakbari 2, Nazila Farrin 4 * Abstract DOI:http://dx.doi.org/10.7314/APJCP.2014.15.14.5733 Effect of Beta Glucan on White Blood Cell Counts and Serum Levels of IL-4 and IL-12 in Women with Breast Cancer Undergoing Chemotherapy: A Randomized

More information

The use of monoclonal antibodies in the setting of HSCT

The use of monoclonal antibodies in the setting of HSCT The use of monoclonal antibodies in the setting of HSCT S Montoto, Barts Cancer Institute, London, UK Geneva 3/April/2012 www.ebmt.org Some definitions of interest: Ab and Ag Antibody (Ab)=Immunoglobulin

More information

Overview of Phase 1 Oncology Trials of Biologic Therapeutics

Overview of Phase 1 Oncology Trials of Biologic Therapeutics Overview of Phase 1 Oncology Trials of Biologic Therapeutics Susan Jerian, MD ONCORD, Inc. February 28, 2008 February 28, 2008 Phase 1 1 Assumptions and Ground Rules The goal is regulatory approval of

More information

The Humoral Immune system Structure and Diversity

The Humoral Immune system Structure and Diversity The Humoral Immune system Structure and Diversity Discussion: Introduction Our immune system protects our bodies from the harmful affects of a dizzying array of disease causing pathogens. Although our

More information

B cell activation and Humoral Immunity

B cell activation and Humoral Immunity B cell activation and Humoral Immunity Humoral immunity is mediated by secreted antibodies and its physiological function is defense against extracellular microbes (including viruses) and microbial exotoxins.

More information

Innate immunity: Definition and Importance. Updated: July 2015

Innate immunity: Definition and Importance. Updated: July 2015 Innate immunity: Definition and Importance Updated: July 2015 1 Contents INNATE IMMUNITY... 3 DEFINITION AND IMPORTANCE... 3 Overview of innate immunity in animals... 3 The innate immune system acts early

More information

Antibody Function & Structure

Antibody Function & Structure Antibody Function & Structure Specifically bind to antigens in both the recognition phase (cellular receptors) and during the effector phase (synthesis and secretion) of humoral immunity Serology: the

More information

Supplemental Material CBE Life Sciences Education. Su et al.

Supplemental Material CBE Life Sciences Education. Su et al. Supplemental Material CBE Life Sciences Education Su et al. APPENDIX Human Body's Immune System Test This test consists of 31 questions, with only 1 answer to be selected for each question. Please select

More information

B Cell Generation, Activation & Differentiation. B cell maturation

B Cell Generation, Activation & Differentiation. B cell maturation B Cell Generation, Activation & Differentiation Naïve B cells- have not encountered Ag. Have IgM and IgD on cell surface : have same binding VDJ regions but different constant region leaves bone marrow

More information

Human Immunity. How our body s cells defend against microbial and viral invaders

Human Immunity. How our body s cells defend against microbial and viral invaders Human Immunity How our body s cells defend against microbial and viral invaders What is Immunity? The word immunity comes from the Latin immunus meaning free of burden. Thus; it is a body s general ability

More information

PROGRAMMA SCIENTIFICO

PROGRAMMA SCIENTIFICO PROGRAMMA SCIENTIFICO MELANOMA BRIDGE 2012, DECEMBER 2 ND -4 TH 2012 Presidents: Paolo A. Ascierto, Francesco M. Marincola and Nicola Mozzillo Scientific Board Paolo A. Ascierto Gennaro Ciliberto Bernard

More information

Transgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO

Transgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO Transgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO Statistically significant difference in progression-free survival continues to be seen in non-squamous

More information

Fetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant. Recipients

Fetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant. Recipients Fetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant Recipients Filippo Milano, 1 J. Lee Nelson, 1, 2 Colleen Delaney 1,3 1 Clinical Research Division, Fred Hutchinson Cancer Research

More information

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic Pulling the Plug on Cancer Cell Communication Stephen M. Ansell, MD, PhD Mayo Clinic Why do Waldenstrom s cells need to communicate? Waldenstrom s cells need activating signals to stay alive. WM cells

More information

CIRM Webinar: CAR-T Cell Immunotherapy - Challenges and Opportunities Using Mature or Stem Memory T Cells, March 18th, 2015 Margo R Roberts, Ph.D.

CIRM Webinar: CAR-T Cell Immunotherapy - Challenges and Opportunities Using Mature or Stem Memory T Cells, March 18th, 2015 Margo R Roberts, Ph.D. CIRM Webinar: CAR-T Cell Immunotherapy - Challenges and Opportunities Using Mature or Stem Memory T Cells, March 18th, 2015 Margo R Roberts, Ph.D. Forward Looking Statements / Safe Harbor To the extent

More information

Engineered T cells. Function (growth factor / effector cytokine / effector molecules) Trafficking chemokine receptors

Engineered T cells. Function (growth factor / effector cytokine / effector molecules) Trafficking chemokine receptors Cell Processing Related Issues: Adoptive T cell Immunotherapy Bernard A. Fox Lab of Molecular and Tumor Immunology Robert W. Franz Cancer Research Center Providence Cancer Center Earle A. Chiles Research

More information

Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years

Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years Claim#:021914-174 Initials: J.T. Last4SSN: 6996 DOB: 5/3/1970 Crime Date: 4/30/2013 Status: Claim is currently under review. Decision expected within 7 days Claim#:041715-334 Initials: M.S. Last4SSN: 2957

More information

Hepatitis C Vaccines: Are we making progress?

Hepatitis C Vaccines: Are we making progress? Hepatitis C Vaccines: Are we making progress? Second International Hepatitis Cure and Eradication Meeting. Vancouver November, 2015 Objectives: Review the need for a preventive vaccine in 2015. Identify

More information

IMMUNOLOGY OF HIV INFECTION AND AIDS. Interactions between HIV and the immune system

IMMUNOLOGY OF HIV INFECTION AND AIDS. Interactions between HIV and the immune system IMMUNOLOGY OF HIV INFECTION AND AIDS Interactions between HIV and the immune system Basic Statistics United States In the U.S. in 2010, 1.1 million people were living with HIV infection. About 50,000 people

More information

Vaccines. Wim Jiskoot Division of Drug Delivery Technology Leiden/Amsterdam Center for Drug Research (LACDR) Leiden University The Netherlands

Vaccines. Wim Jiskoot Division of Drug Delivery Technology Leiden/Amsterdam Center for Drug Research (LACDR) Leiden University The Netherlands Vaccines Wim Jiskoot Division of Drug Delivery Technology Leiden/Amsterdam Center for Drug Research (LACDR) Leiden University The Netherlands None Statement of conflict Learning outcomes Know which categories

More information

Making the switch to a safer CAR-T cell therapy

Making the switch to a safer CAR-T cell therapy Making the switch to a safer CAR-T cell therapy HaemaLogiX 2015 Technical Journal Club May 24 th 2016 Christina Müller - chimeric antigen receptor = CAR - CAR T cells are generated by lentiviral transduction

More information

Bottle-neck Problems of Current Human Cancer Therapy

Bottle-neck Problems of Current Human Cancer Therapy International Conference on Human Cell, Tissue-based Products and Tissue Banks, Oct. 13-14,Taipei, Taiwan Autologous Dendritic Cell-based Immunotherapy of Glioblastoma Multiforme: Post-Phase-I Clinical

More information

Mouse IFN-gamma ELISpot Kit

Mouse IFN-gamma ELISpot Kit Page 1 of 8 Mouse IFN-gamma ELISpot Kit Without Plates With Plates With Sterile Plates Quantity Catalog Nos. 862.031.001 862.031.001P 862.031.001S 1 x 96 tests 862.031.005 862.031.005P 862.031.005S 5 x

More information

T h. Immunity. Why? Model 1 Cell Mediated Response. How does our immune system protect us from disease?

T h. Immunity. Why? Model 1 Cell Mediated Response. How does our immune system protect us from disease? Why? Immunity How does our immune system protect us from disease? One way in which organisms maintain homeostasis is by detecting foreign cells and particles like pathogens and cancer cells. Once the pathogen

More information

The Costimulatory Molecule CD27 Maintains Clonally

The Costimulatory Molecule CD27 Maintains Clonally Immunity, Volume 35 Supplemental Information The Costimulatory Molecule CD7 Maintains Clonally Diverse CD8 + T Cell Responses of Low Antigen Affinity to Protect against Viral Variants Klaas P.J.M. van

More information

DNA METHYLATION AND THE CONCEPT OF EPIGENETICS

DNA METHYLATION AND THE CONCEPT OF EPIGENETICS DNA METHYLATION AND THE CONCEPT OF EPIGENETICS The term Epigenetics describes heritable genetic modifications that are not attributable to changes in the primary DNA sequence. Epigenetic modifications

More information

EU Media Inquiries: Satu Kaarina Glawe Phone: +49 (0) 2638 947 9218 Mobile: +49 (172) 294 6264 Email: sglawe@its.jnj.com

EU Media Inquiries: Satu Kaarina Glawe Phone: +49 (0) 2638 947 9218 Mobile: +49 (172) 294 6264 Email: sglawe@its.jnj.com EU Media Inquiries: Satu Kaarina Glawe Phone: +49 (0) 2638 947 9218 Mobile: +49 (172) 294 6264 Email: sglawe@its.jnj.com Investor Relations: Stan Panasewicz Phone: +1 732-524-2524 Louise Mehrotra Phone:

More information

Autoimmunity and immunemediated. FOCiS. Lecture outline

Autoimmunity and immunemediated. FOCiS. Lecture outline 1 Autoimmunity and immunemediated inflammatory diseases Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline Pathogenesis of autoimmunity: why selftolerance fails Genetics of autoimmune diseases Therapeutic

More information

Discussion of natural killer cells and innate immunity. Theresa L. Whiteside, Ph.D. University of Pittsburgh Cancer Institute Pittsburgh, PA 15213

Discussion of natural killer cells and innate immunity. Theresa L. Whiteside, Ph.D. University of Pittsburgh Cancer Institute Pittsburgh, PA 15213 Discussion of natural killer cells and innate immunity Theresa L. Whiteside, Ph.D. University of Pittsburgh Cancer Institute Pittsburgh, PA 15213 Myths in tumor immunology Cancer cells are ignored by the

More information

Topic I DNA Vaccines

Topic I DNA Vaccines Seminar Molecular Mechanisms in Health and Disease Topic I DNA Vaccines King CA, Spellerberg MB, Zhu D, Rice J, Sahota SS, Thompsett AR, Hamblin TJ, Radl J, Stevenson FK DNA vaccines with single chain

More information

The Body s Defenses CHAPTER 24

The Body s Defenses CHAPTER 24 CHAPTER 24 The Body s Defenses PowerPoint Lectures for Essential Biology, Third Edition Neil Campbell, Jane Reece, and Eric Simon Essential Biology with Physiology, Second Edition Neil Campbell, Jane Reece,

More information

Chapter 22: Lymphatic System and Immunity

Chapter 22: Lymphatic System and Immunity I. Lymphatic System A. Functions of the Lymphatic System - list and describe: 1. 2. 3. B. Lymphatic Vessels 1. What are lymphatic capillaries? 2. Lymphatic capillaries differ from blood capillaries in

More information

Advances in Treatment of Malignant Pleural Mesothelioma: A Reason for Hope

Advances in Treatment of Malignant Pleural Mesothelioma: A Reason for Hope Advances in Treatment of Malignant Pleural Mesothelioma: A Reason for Hope Daniel H. Sterman, M.D. Associate Professor of Medicine and Surgery Co-Director, PENN Mesothelioma and Pleural Program University

More information

Host defenses to viral infections

Host defenses to viral infections Host defenses to viral infections 1) General Skin, mucus, low gastric ph 2) Innate immune system Non-specific, no long lasting immunity, dominant immune system found in plants, primitive animals 3) Adaptive

More information

Combining Immunotherapy and Targeted Therapy in Melanoma

Combining Immunotherapy and Targeted Therapy in Melanoma Combining Immunotherapy and Targeted Therapy in Melanoma 8:45 am - 9:15 am Antoni Ribas, M.D., h.d. rofessor of Medicine rofessor of Surgery rofessor of Molecular and Medical harmacology Director, Tumor

More information

Lymphatic/Immune System Vocabulary Key

Lymphatic/Immune System Vocabulary Key Term Acquired Immunity Adenoids Antibody Antigen Axillary nodes B cell (B lymphocyte) Cervical nodes Complement system Cytokines Cytotoxic T cell Dendritic cell Helper T cell Immunity Immunoglobulins Immunotherapy

More information

THE IMMUNE SYSTEM. Molecules, cells, tissues and organs which provide non-specific and specific protection against

THE IMMUNE SYSTEM. Molecules, cells, tissues and organs which provide non-specific and specific protection against Immune system Acknowledgement Material used in some of the slides was taken from open websites and personnel communications. Help from these sites and providers is acknowledged. THE IMMUNE SYSTEM Molecules,

More information

HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13

HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13 SECTION 13 HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES CONTACT INFORMATION Jason Cyster, PhD (Email) READING Basic Immunology: Functions and Disorders of the Immune System. Abbas,

More information